Inventor · disambiguated record
Hadas Reuveni
Also filed as: REUVENI HADAS
12 granted patents·6 pending applications·20 citations·filing 1996–2025
85Inventor score
Files withTYRNOVO LTD6REUVENI HADAS4YISSUM RES DEV CO4YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD2CHILDRENS MEDICAL CENTER1
Top patents by PatentIndex Score
18 records- 0176US7683031B2Short peptides from the ‘2nd loop’ of 7 transmembrane receptor which selectively modulate signal transductionYISSUM RES DEV CO·Filed 2003·Granted Mar 23, 2010·4 cites·16 claims
- 0273US8058309B2Protein kinase modulators and therapeutic uses thereofREUVENI HADAS·Filed 2007·Granted Nov 15, 2011·6 cites·14 claims
- 0370US9073880B22-(2-phenylethenyl) 1,3-benzodiazepine derivatives useful for the treatment of cancerREUVENI HADAS·Filed 2011·Granted Jul 7, 2015·1 cites·18 claims
- 0469US8637575B2Modulators of protein kinase signalingREUVENI HADAS·Filed 2009·Granted Jan 28, 2014·1 cites·20 claims
- 0567US10912745B2Combinations of IRS/Stat3 dual modulators and anti-cancer agents for treating cancerTYRNOVO LTD·Filed 2016·Granted Feb 9, 2021·1 cites·12 claims
- 0665US6949565B2Protein kinase inhibitorsYISSUM RES DEV CO·Filed 2001·Granted Sep 27, 2005·3 cites·21 claims
- 0761US12201592B2Combinations of IRS/STAT3 dual modulators and anti-cancer agents for treating cancerTYRNOVO LTD·Filed 2021·Granted Jan 21, 2025·0 cites·16 claims
- 0860US2024067604A1Combinations of irs/stat3 dual modulators and anti pd-1/pd-l1 antibodies for treating cancerTYRNOVO LTD·Filed 2023·Application pending·0 cites
- 0957US2025134837A1Combinations of irs/stat3 dual modulators and anti-cancer agents for treating cancerTYRNOVO LTD·Filed 2025·Application pending·0 cites
- 1056US2024425452A1Isolated trans isomer of 3-(2-bromo-3,4-dihydroxy-phenyl)-n-(3,4,5-trihydroxy-benzyl)-thioacrylamideTYRNOVO LTD·Filed 2022·Application pending·0 cites
- 1155US9770454B2IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseasesYISSUM RES DEV CO·Filed 2014·Granted Sep 26, 2017·0 cites·12 claims
- 1254US10188659B2IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseasesYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2017·Granted Jan 29, 2019·0 cites·11 claims
- 1349US2004121952A1Treatment of cancerCHILDRENS MEDICAL CENTER·Filed 2003·Application pending·0 cites
- 1448US9873724B2Pro-angiogenic peptides and peptide conjugatesYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2014·Granted Jan 23, 2018·0 cites·14 claims
- 1545US5990277ASemipeptoid farnesyl protein transferase inhibitors and analogs thereofYISSUM RES DEV CO·Filed 1996·Granted Nov 23, 1999·4 cites·10 claims
- 1638US2020369607A1Combinations of irs/stat3 dual modulators and anti pd-1/pd-l1 antibodies for treating cancerTYRNOVO LTD·Filed 2017·Application pending·0 cites
- 1735US8575307B2Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetesSHAFRIR ELEAZAR·Filed 2006·Granted Nov 5, 2013·0 cites·5 claims
- 1829US2012083528A1Novel protein kinase modulators and therapeutic uses thereofREUVENI HADAS·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hadas Reuveni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →